Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TAHO Pharmaceuticals Ltd (6467) AI Stock Analysis

TW:6467

TAHO Pharmaceuticals Ltd

(TWSE:6467)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

TAHO Pharmaceuticals Ltd (6467) vs. SPDR S&P 500 ETF (SPY)

-50%-25%0%25%50%75%TW:6467+36.50%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 12.89B
Dividend Yield
―
Average Volume (3M)
1.22M
Price to Earnings (P/E)
-55.2
Beta (1Y)
-4.54
Revenue Growth
―
EPS Growth
-13.00%
Country
TW
Employees
―
Sector
General
Sector Strength
55
Industry
―

TAHO Pharmaceuticals Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:6467 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:1720TW:172071OutperformTWD 10.81B10.82―3.62%4.62%9.56%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:6576TW:657642NeutralTWD 11.52B519.28――6.41%―
TW:6617TW:661740UnderperformTWD 15.11B-92.22――11.66%-72.96%
TW:6945TW:694540UnderperformTWD 11.22B-21.76――――
TW:6535TW:653539UnderperformTWD 12.33B-33.67――-24.84%9.09%

* General Sector Average

Performance Comparison

-50%0%50%100%TW:6467TW:1720TW:6535TW:6576TW:6617TW:6945Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:6467 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:6467TAHO Pharmaceuticals Ltd230.0056.5032.56%
TW:1720Standard Chemical & Pharmaceutical Co. Ltd.55.201.492.78%
TW:6535LUMOSA THERAPEUTICS CO LTD80.80-107.20-57.02%
TW:6576Foresee Pharmaceuticals Co., Ltd.73.00-4.50-5.81%
TW:6617Gongwin Biopharm Holdings Co., Ltd.126.5041.9049.53%
TW:6945AP Biosciences, Inc.117.506.005.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.